Advisory boards, speaker programs, consulting arrangements, sponsorships, meal programs. Every interaction between your company and a healthcare professional creates compliance risk. The question is whether your process for managing it will hold up under scrutiny.
The Anti-Kickback Statute doesn't care about your intentions. It cares about whether compensation to HCPs could be construed as inducement for prescribing, referring, or recommending. Every advisory board, every speaker fee, every consulting payment is evaluated against that standard.
The most common problems we see aren't dramatic fraud. They're structural failures: advisory boards without a documented legitimate business need. Speaker programs where the same 10 physicians get selected every year with no defensible criteria. Consulting arrangements with no deliverables. Fair market value rates pulled from a benchmark without any tiering methodology.
These don't start as compliance problems. They start as business decisions made without compliance input. By the time someone notices, there's a pattern, and patterns are what investigators look for.
A structured HCP engagement workflow that requires legitimate business need documentation before an engagement begins, not after. This includes needs assessments that connect the engagement to a real business or scientific question, selection criteria that are objective and documented, FMV rates that are defensible, and an approval process that routes through compliance before commitments are made.
Monitoring that catches problems during the engagement lifecycle, not in a year-end audit. Aggregate spend tracking that flags when an HCP is approaching a threshold. Frequency monitoring that identifies over-utilization. Agenda and format review that ensures advisory boards have enough discussion time to be legitimate, not just disguised promotion.
Documentation that produces an audit trail. Every engagement, every decision, every approval recorded and organized. When OIG or a state AG requests your records for a specific HCP, you can produce a complete file, not a scramble through email threads.
Advisory boards and ad hoc consultancies. The highest-risk, highest-value HCP interactions. We review the concept, the HCP selection, the agenda, the rates, and the documentation.
Speaker programs and peer-to-peer education. Speaker selection, training compliance, slide review, program monitoring, and the ongoing question of whether the program is still serving a legitimate educational purpose.
Sponsorships and exhibits. Conference sponsorships, CME grants, exhibit booths. State transparency reporting obligations vary by state, and the aggregate spend implications are easy to miss.
Market research and consulting. When does a consulting arrangement stop being legitimate and start looking like a payment for access? The answer depends on the deliverables, the documentation, and the pattern.
If you're running HCP engagements without a structured compliance process, or if you have one that doesn't feel airtight, we can walk through what a defensible program looks like. Most compliance gaps are fixable. The ones that aren't are the ones nobody looked at.
Schedule a Consultation